Investor insights
Sectors invested in
Monoclonal antibodies1
Biotechnology1
Anticorps monoclonaux1
Therapeutic antibodies1
vascular microenvironment1
Anticorps thérapeutiques1
ophtalmologie1
aGvHD1
immune microenvironment1
Therapeutics1
Health Care1
Funding rounds participated in
$2.7M sweet spot round size
Most of their 1 investments are in rounds between $2.7M and $2.7M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Manufacturing
Pharmaceutical
Date founded
1979
Investments made
E
ELSALYS BIOTECH raised $2.7M on May 17, 2013
Investors: Sofimacpartners and Transgene
Funding rounds raised
Total raised
$22M
from 1 investors over 1 rounds
T
Transgene raised $22M on April 2, 2019
Investors: Natixis